Paper40920775
Targeting the Exon2 splice cis-element in PD-1 and its effects on lymphocyte function.
Tan Y and 6 others. PLoS One, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Targeting the Exon2 splice cis-element in PD-1 and its effects on lymphocyte function. Papers, record 40920775. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40920775
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Programmed Cell Death 1 Receptor | Major topic |
| Exons | Major topic |
| CD8-Positive T-Lymphocytes | Major topic |
| RNA Splicing | Major topic |
| Humans | |
| CRISPR-Cas Systems | |
| Cytokines | |
| RNA Precursors | |
| Lymphocyte Activation | |
| Cell Proliferation |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38823437 | DC-derived CXCL10 promotes CTL activation to suppress ovarian cancer. | Transl Res | 2024 | https://conductscience.org/library/papers/38823437 | PubMed |
| 2 | 38043270 | An anti-PD-1 antisense oligonucleotide promotes the expression of soluble PD-1 by blocking the interaction between SRSF3 and an exonic splicing enhancer of PD-1 exon 3. | Int Immunopharmacol | 2024 | https://conductscience.org/library/papers/38043270 | PubMed |
| 3 | 28881701 | PD1 signal transduction pathways in T cells. | Oncotarget | 2017 | https://conductscience.org/library/papers/28881701 | PubMed |
| 4 | 37124148 | Non-viral chimeric antigen receptor (CAR) T cells going viral. | Immunooncol Technol | 2023 | https://conductscience.org/library/papers/37124148 | PubMed |
| 5 | 12969992 | Fractalkine in vascular biology: from basic research to clinical disease. | Arterioscler Thromb Vasc Biol | 2004 | https://conductscience.org/library/papers/12969992 | PubMed |
| 6 | 36002647 | Eosinophil-lymphocyte interactions in the tumor microenvironment and cancer immunotherapy. | Nat Immunol | 2022 | https://conductscience.org/library/papers/36002647 | PubMed |
| 7 | 31611251 | Biology and therapeutic potential of interleukin-10. | J Exp Med | 2020 | https://conductscience.org/library/papers/31611251 | PubMed |
| 8 | 37907738 | CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/37907738 | PubMed |
| 9 | 38401888 | PD-1 regulation in immune homeostasis and immunotherapy. | Cancer Lett | 2024 | https://conductscience.org/library/papers/38401888 | PubMed |
| 10 | 8057683 | Establishment and characterization of the T-cell line, EBT-8 latently infected with Epstein-Barr virus from large granular lymphocyte leukemia. | Leukemia | 1994 | https://conductscience.org/library/papers/8057683 | PubMed |
| 11 | 23223433 | The role of B7 family molecules in hematologic malignancy. | Blood | 2013 | https://conductscience.org/library/papers/23223433 | PubMed |
| 12 | 36525971 | IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer. | Cancer Cell | 2023 | https://conductscience.org/library/papers/36525971 | PubMed |
| 13 | 10837060 | CD8+ T cell effector mechanisms in resistance to infection. | Annu Rev Immunol | 2000 | https://conductscience.org/library/papers/10837060 | PubMed |
| 14 | 38660299 | Targeting PD-1/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges. | Front Immunol | 2024 | https://conductscience.org/library/papers/38660299 | PubMed |
| 15 | 24240160 | A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application. | Nat Immunol | 2013 | https://conductscience.org/library/papers/24240160 | PubMed |
| 16 | 21830940 | Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21830940 | PubMed |
| 17 | 15292066 | IL-8 responsiveness defines a subset of CD8 T cells poised to kill. | Blood | 2004 | https://conductscience.org/library/papers/15292066 | PubMed |
| 18 | 32665590 | Structure-based design of gRNA for Cas13. | Sci Rep | 2020 | https://conductscience.org/library/papers/32665590 | PubMed |
| 19 | 12445288 | GM-CSF-based cancer vaccines. | Immunol Rev | 2002 | https://conductscience.org/library/papers/12445288 | PubMed |
| 20 | 26558876 | CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition. | Am J Clin Oncol | 2016 | https://conductscience.org/library/papers/26558876 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41457218 | RNA modifications: roles in immune cell biology and tumor regulation. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/41457218 |
Source PubMed
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CSF2 | 1437 | PubTator's text mining | https://conductscience.org/library/genes/1437 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
| TRBV20OR9-2 | 6962 | PubTator's text mining | https://conductscience.org/library/genes/6962 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40920775
GET https://conductscience.org/api/papers/v1/40920775/references?page=2